{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:52:42Z","timestamp":1793811162548,"version":"4.6.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"20","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>To address acute vaso-occlusive episodes (VOEs), the leading cause of emergency department (ED) visits among individuals with sickle cell disease (SCD), we conducted the clinical study, ALIGN (An Individualized Pain Plan with Patient and Provider Access for Emergency Department care of SCD), across 8 sites. We hypothesized an improvement of 0.5 standard deviations in perceived quality of ED pain treatment of a VOE after implementing individualized pain plans (IPPs) accessible to both patients and providers. Patients with SCD were aged 18 to 45 years, owned a cell phone, and had an ED VOE visit within 90\u00a0days prior. Patients completed the perceived quality of care surveys at baseline and within 96 hours after an ED VOE visit. Providers completed surveys regarding comfort managing VOEs at baseline and after managing an enrolled patient. Most of the 153 patients were African American (95.4%), female (64.7%), and had Hb SS\/S\u03b20 genotype (71.9%). The perceived quality of ED pain treatment was high at both baseline and after implementation of IPPs; our primary outcome hypothesis was not met, because no statistically significant change in the patient-perceived quality of ED treatment occurred. A total of 135 providers completed baseline and follow-up surveys. On a scale of 1 to 7, with 7 being extremely comfortable managing VOEs, 60.5% reported a score \u22656 after IPP implementation vs 57.8% at baseline. Almost all (97.6%) ordered the recommended medication, and 94.7% intended to use IPPs. In this implementation protocol, all sites successfully implemented IPPs. Patients and ED providers both endorsed the use of IPPs. This trial was registered at www.ClinicalTrials.gov as # NCT04584528.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012439","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T15:58:50Z","timestamp":1717084730000},"page":"5330-5338","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency department"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4941-5069","authenticated-orcid":false,"given":"Lauren","family":"Siewny","sequence":"first","affiliation":[{"name":"1Department of Emergency Medicine, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-6176","authenticated-orcid":false,"given":"Allison","family":"King","sequence":"additional","affiliation":[{"name":"2Division of Pediatric Hematology and Oncology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy L.","family":"Melvin","sequence":"additional","affiliation":[{"name":"3Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2603-7157","authenticated-orcid":false,"given":"Christopher R.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"4Department of Emergency Medicine, Mayo Clinic-Rochester, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-7321","authenticated-orcid":false,"given":"Jane S.","family":"Hankins","sequence":"additional","affiliation":[{"name":"5Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-6553","authenticated-orcid":false,"given":"Joseph S.","family":"Colla","sequence":"additional","affiliation":[{"name":"6Department of Emergency Medicine, University of Illinois College of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-7260","authenticated-orcid":false,"given":"Liliana","family":"Preiss","sequence":"additional","affiliation":[{"name":"7Division of Statistics and Epidemiology, RTI International, Research Triangle Park, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzi","family":"Luo","sequence":"additional","affiliation":[{"name":"8School of Global Public Health, New York University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-7480","authenticated-orcid":false,"given":"Lisa","family":"Cox","sequence":"additional","affiliation":[{"name":"9RTI International, Research Triangle Park, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0521-1846","authenticated-orcid":false,"given":"Marsha","family":"Treadwell","sequence":"additional","affiliation":[{"name":"10Division of Hematology, Department of Pediatrics, University of California, San Francisco, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Davila","sequence":"additional","affiliation":[{"name":"11College of Nursing, Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-8840","authenticated-orcid":false,"given":"Rita V.","family":"Masese","sequence":"additional","affiliation":[{"name":"12School of Nursing, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7489-9894","authenticated-orcid":false,"given":"Sarah","family":"McCuskee","sequence":"additional","affiliation":[{"name":"13Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Siera","family":"Gollan","sequence":"additional","affiliation":[{"name":"14Center for Blood Disorders, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Tanabe","sequence":"additional","affiliation":[{"name":"15Duke University School of Nursing and School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"3S","key":"2024102212353562800_bib1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2024102212353562800_bib2","doi-asserted-by":"crossref","first-page":"e0216414","DOI":"10.1371\/journal.pone.0216414","article-title":"Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: the emergency department providers' perspective","volume":"14","author":"Masese","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"2024102212353562800_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"issue":"suppl 4","key":"2024102212353562800_bib4","doi-asserted-by":"crossref","first-page":"S536","DOI":"10.1016\/j.amepre.2010.01.001","article-title":"Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007","volume":"38","author":"Yusuf","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3","key":"2024102212353562800_bib5","first-page":"227","article-title":"Safety of an ED high-dose opioid protocol for cickle cell disease pain","volume":"41","author":"Tanabe","year":"2015","journal-title":"J\u00a0Emerg Nurs"},{"key":"2024102212353562800_bib6","unstructured":"U.S. Department of Health and Human Services National Heart Lung, and Blood Institute\n          . Evidence-based management of sickle cell disease, expert panel report, 2014. 2014. Accessed 1 June 2024. http:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/sickle-cell-disease-guidelines\/."},{"issue":"2","key":"2024102212353562800_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.24948","article-title":"A\u00a0randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe","year":"2018","journal-title":"Am J Hematol"},{"issue":"12","key":"2024102212353562800_bib8","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"2024102212353562800_bib9","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1002\/ajh.25282","article-title":"The sickle cell disease implementation consortium: translating evidence-based guidelines into practice for sickle cell disease","volume":"93","author":"DiMartino","year":"2018","journal-title":"Am J Hematol"},{"issue":"4","key":"2024102212353562800_bib10","doi-asserted-by":"crossref","first-page":"e24818","DOI":"10.2196\/24818","article-title":"Electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease: protocol for a preimplementation and postimplementation study","volume":"10","author":"Luo","year":"2021","journal-title":"JMIR Res Protoc"},{"key":"2024102212353562800_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"9","key":"2024102212353562800_bib12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"issue":"35","key":"2024102212353562800_bib13","doi-asserted-by":"crossref","first-page":"e4528","DOI":"10.1097\/MD.0000000000004528","article-title":"Quality of care in sickle cell disease: cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care","volume":"95","author":"Evensen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2024102212353562800_bib14","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"2024102212353562800_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijmedinf.2014.08.003","article-title":"Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation","volume":"83","author":"Kato-Lin","year":"2014","journal-title":"Int J Med Inform"},{"issue":"3S","key":"2024102212353562800_bib16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.annemergmed.2020.08.008","article-title":"The effect of use of individualized pain plans in sickle cell patients presenting to the emergency department","volume":"76","author":"Della-Moretta","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2024102212353562800_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ejh.13924","article-title":"Time to pain relief: a randomized controlled trial in the emergency department during vaso-occlusive episodes in sickle cell disease","volume":"110","author":"Tanabe","year":"2023","journal-title":"Eur J Haematol"},{"issue":"1","key":"2024102212353562800_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12245-022-00438-0","article-title":"Patient-centered care in the emergency department: a systematic review and meta-ethnographic synthesis","volume":"15","author":"Walsh","year":"2022","journal-title":"Int J Emerg Med"},{"issue":"5","key":"2024102212353562800_bib19","doi-asserted-by":"crossref","first-page":"e206016","DOI":"10.1001\/jamanetworkopen.2020.6016","article-title":"Perceptions of US adolescents and adults with sickle cell disease on their quality of care","volume":"3","author":"Kanter","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2024102212353562800_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency provider analgesic practices and attitudes towards patients with sickle cell disease","volume":"62","author":"Glassberg","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"3S","key":"2024102212353562800_bib21","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.annemergmed.2020.08.013","article-title":"A\u00a0survey-based needs assessment of barriers to optimal sickle cell disease care in the emergency department","volume":"76","author":"Linton","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"12","key":"2024102212353562800_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/acem.14805","article-title":"A\u00a0comparison of the effect of patient-specific vs. weight-based protocols to treat vaso-occlusive episodes (VOE) in the emergency department","volume":"30","author":"Tanabe","year":"2023","journal-title":"Acad Emerg Med"},{"key":"2024102212353562800_bib23","unstructured":"National Association of Sickle Cell Centers\n          . Resources: opioid dosing calculator for people with sickle cell disease. Accessed 1 June 2024. https:\/\/sicklecellcenters.org\/provider_resources."},{"issue":"1","key":"2024102212353562800_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1186\/s12913-023-10255-7","article-title":"\"The project did not come to us with a solution\": perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease","volume":"23","author":"Baumann","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2024102212353562800_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/TME.0000000000000232","article-title":"Exploring emergency department provider experiences with and perceptions of weight-based versus individualized vaso-occlusive treatment protocols in sickle cell disease","volume":"41","author":"Knight","year":"2019","journal-title":"Adv Emerg Nurs J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/20\/5330\/2247365\/blooda_adv-2023-012439-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/20\/5330\/2247365\/blooda_adv-2023-012439-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T08:35:53Z","timestamp":1729586153000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/20\/5330\/516311\/Impact-of-an-individualized-pain-plan-to-treat"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":25,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,10,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012439","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]}}}